Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viracta Therapeutics Inc (NQ: VIRX )

1.040 -0.010 (-0.95%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 27,504
Open 1.050
Bid (Size) 1.010 (10)
Ask (Size) 1.150 (1)
Prev. Close 1.050
Today's Range 1.040 - 1.110
52wk Range 0.8750 - 4.680
Shares Outstanding 38,410,935
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Expert Ratings for Viracta Therapeutics
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Via Benzinga

Performance

YTD
-26.76%
-26.76%
1 Month
-26.76%
-26.76%
3 Month
-26.24%
-26.24%
6 Month
-34.59%
-34.59%
1 Year
-74.57%
-74.57%

More News

Read More
Viracta Therapeutics Says Pivotal Cancer Trial Achieves Efficacy Threshold For Expansion Into Next Stage
Via Benzinga
Analyst Ratings for Viracta Therapeutics
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
Via Benzinga
Viracta Obtains Orphan Drug Status From European Commission For T-cell Lymphoma Candidate
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
79 Biggest Movers From Yesterday
Via Benzinga
34 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
68 Biggest Movers From Yesterday
Via Benzinga
53 Biggest Movers From Yesterday
Via Benzinga
64 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.